Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSR411298 in Elderly Patients with Major Depressive Disorder
NCT00822744Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of SSR411298 in major depressive disorder (MDD), sponsored by Sanofi. Started Dec 2008; status: completed.
02
Drugs
SSR411298
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00822744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822744.